• English
  • 简体中文
Login Register
Current Location: Home > FDA Approved Drug Products Feedback Help
-
-
Application Number Application Type Drug Name Active Ingredients Dosage Form/Route Approval Date Company
217006 NDA ABILIFY ASIMTUFII ARIPIPRAZOLE SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR 2023-04-27 OTSUKA
216351 ANDA ARIPIPRAZOLE ARIPIPRAZOLE SOLUTION;ORAL 2022-10-27 RUBICON
216150 ANDA ARIPIPRAZOLE ARIPIPRAZOLE SOLUTION;ORAL HETERO LABS LTD III
215595 ANDA ARIPIPRAZOLE ARIPIPRAZOLE SOLUTION;ORAL 2022-10-25 CHARTWELL RX
213037 ANDA ARIPIPRAZOLE ARIPIPRAZOLE TABLET;ORAL SUNSHINE
212870 ANDA ARIPIPRAZOLE ARIPIPRAZOLE SOLUTION;ORAL 2019-12-26 VISTAPHARM
210479 ANDA ARIPIPRAZOLE ARIPIPRAZOLE SOLUTION;ORAL 2019-01-29 AUROBINDO PHARMA LTD
209830 NDA ARISTADA INITIO KIT ARIPIPRAZOLE LAUROXIL SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR 2018-06-29 ALKERMES INC
208438 ANDA ARIPIPRAZOLE ARIPIPRAZOLE TABLET, ORALLY DISINTEGRATING;ORAL 2018-12-26 PHARMTAK INC
208260 ANDA ARIPIPRAZOLE ARIPIPRAZOLE TABLET;ORAL 2018-12-26 PHARMTAK INC
207533 NDA ARISTADA ARIPIPRAZOLE LAUROXIL SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR 2015-10-05 ALKERMES INC
207240 ANDA ARIPIPRAZOLE ARIPIPRAZOLE TABLET, ORALLY DISINTEGRATING;ORAL 2018-04-18 SCIEGEN PHARMS INC
207202 NDA ABILIFY MYCITE KIT ARIPIPRAZOLE TABLET;ORAL 2017-11-13 OTSUKA
207105 ANDA ARIPIPRAZOLE ARIPIPRAZOLE TABLET;ORAL 2019-02-21 ALKEM LABS LTD
206383 ANDA ARIPIPRAZOLE ARIPIPRAZOLE TABLET;ORAL 2016-09-29 SCIEGEN PHARMS INC
206251 ANDA ARIPIPRAZOLE ARIPIPRAZOLE TABLET;ORAL 2016-12-07 ACCORD HLTHCARE
206240 ANDA ARIPIPRAZOLE ARIPIPRAZOLE TABLET;ORAL 2018-09-19 MYLAN
206174 ANDA ARIPIPRAZOLE ARIPIPRAZOLE TABLET;ORAL 2016-09-12 AJANTA PHARMA LTD
205363 ANDA ARIPIPRAZOLE ARIPIPRAZOLE TABLET;ORAL 2017-12-04 PRINSTON INC
205064 ANDA ARIPIPRAZOLE ARIPIPRAZOLE TABLET;ORAL 2015-04-28 HETERO LABS LTD V